Tag: ASX:RAC
Aussie biotech firm completes bisantrene cGMP API manufacturing with Indian partner
Race Oncology Limited announced that Laurus Labs, an India-based pharmaceutical manufacturer, has produced its first batch of bisantrene dihydrochloride, Race’s active pharmaceutical ingredient (API), to a standard that meets the quality specified under the ‘Code of Good Manufacturing Practice’ (cGMP).
Featured Article
AMCA Impact Study highlights AI’s role in improving HVAC safety compliance
A new AMCA Impact Study has highlighted the growing challenge of helping HVAC contractors access reliable safety and compliance information quickly, particularly for small and medium-sized businesses operating in Australia's highly regulated construction environment.
